Related Experiment Video
Updated: Jan 4, 2026

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
[Effect of microRNA-133b on Myocardial Fibrosis]
Song Lin Zhang1, Fen Ling Fan1, Feng Wei1
1Department of Structural Heart Disease,the First Affiliated Hospital of Xiߣan Jiaotong University,Xiߣan 710061,China.
Abstract:
Objective To investigate the effect of microRNA-133b(miR-133b)on cardiac fibrosis and its mechanism.Methods Human cardiac fibroblasts(CFs)were harvested.The proliferation of CFs was detected by CCK8 during the overexpression and knock-down of miR-133b.The expressions of connective tissue growth factor(CTGF),α-smooth muscle actin(α-SMA),collagen Ⅰ,and collagen Ⅲ were detected with qRT-PCR and Western blot analysis after miR-133b overexpression or downexpression.Target genes of miR-133b were predicted by bioinformatics software.Dual-luciferase activity assay were used to verify a target gene of miR-133b.Results qRT-PCR showed that the expression level of miR-133b in the miR-133b mimic group was significantly higher than that in the negative control group(t=26.219,P=0.000).The expression level of miR-133b in the miR-133b inhibitor group was significantly lower than that in the negative control group(t=6.738,P=0.003).After 21,45,69,93,and 117 hours of transfection,the proliferation ability of CFs significantly decreased in the miR-133b mimic group but significantly increased in the miR-133b group(all P<0.05,compared with the negative control group).After overexpression of miR-133b,the mRNA and protein levels of CTGF(t=9.213,P=0.001;t=8.195,P=0.001),α-SMA(t=6.511,P =0.003;t=4.434,P=0.011),collagenⅠ(t=3.172,P=0.034;t=4.053,P=0.015)and collagen Ⅲ(t=6.404,P=0.003;t=5.319,P=0.006)were significantly down-regulated.After the expression of miR-133b was knocked down,the mRNA and protein levels of CTGF(t=9.439,P=0.001;t=14.100,P=0.000),α-SMA(t=4.519,P=0.011;t=4.377,P=0.012),collagen Ⅰ(t=5.966,P=0.004;t=5.514,P=0.005)and collagen Ⅲ(t=4.622,P=0.010;t=4.996,P=0.008)were significantly increased.The relative luciferase activity of the cells co-transfected with miR-133b mimic and WT 3'UTR expression vector was significantly lower than that of the cells co-transfected with mimic control and WT 3'UTR expression vectors(t=5.654,P=0.005);however,there was no significant difference in relative luciferase activity between cells co-transfected with miR-133b mimic and MUT 3'UTR expression vectors and cells co-transfected with mimic control and MUT 3'UTR expression vectors(t=0.380,P=0.724).Conclusion miR-133b may affect the activation and proliferation of CFs by targeting CTGF and thus improve cardiac fibrosis.
Insights
MicroRNA-133b (miR-133b) inhibits cardiac fibroblast proliferation and reduces fibrosis markers by targeting connective tissue growth factor (CTGF). This suggests miR-133b has therapeutic potential for cardiac fibrosis.
Area of Science:
- Cardiovascular Biology
- Molecular Medicine
- MicroRNA Research
Background:
- Cardiac fibrosis is a significant contributor to heart failure.
- MicroRNAs play crucial roles in regulating cardiac structure and function.
- The specific role of microRNA-133b (miR-133b) in cardiac fibrosis remains to be fully elucidated.
Purpose of the Study:
- To investigate the effect of miR-133b on cardiac fibroblast (CF) proliferation and activation.
- To explore the underlying mechanism by which miR-133b influences cardiac fibrosis.
- To identify potential therapeutic targets for mitigating cardiac fibrosis.
Main Methods:
- Human cardiac fibroblasts (CFs) were cultured and transfected with miR-133b mimics or inhibitors.
- Cell proliferation was assessed using CCK8 assays.
- Gene and protein expression of fibrosis markers (CTGF, α-SMA, collagen I, collagen III) were quantified via qRT-PCR and Western blot.
- Bioinformatics and dual-luciferase reporter assays were employed to validate miR-133b targets.
Main Results:
- Overexpression of miR-133b significantly decreased CF proliferation and downregulated CTGF, α-SMA, collagen I, and collagen III expression.
- Knockdown of miR-133b significantly increased CF proliferation and upregulated these fibrosis markers.
- Dual-luciferase assays confirmed that miR-133b directly targets CTGF.
Conclusions:
- miR-133b plays a protective role against cardiac fibrosis by inhibiting CF activation and proliferation.
- Targeting CTGF is a key mechanism through which miR-133b exerts its antifibrotic effects.
- miR-133b holds promise as a therapeutic agent for treating cardiac fibrosis.
More Related Videos
09:16Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
08:56Detection of microRNA Expression in Peritoneal Membrane of Rats Using Quantitative Real-time PCR
Published on: June 27, 2017
Related Concept Videos
Myocarditis I: Introduction
MicroRNAs
MicroRNAs